What does this research mean for the field?

Matrix-embedded dual-drug eluting biodegradable sutures produced via solvent-free hot-melt extrusion provide immediate and sustained release of levofloxacin and ibuprofen to prevent surgical site infections and control inflammation. Novelty: ClaimNovelty.METHODOLOGICAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The aim is to develop biodegradable sutures that release antibiotics and anti-inflammatories to prevent infections after surgery.

June 3, 2026Open Access

Engineering matrix-embedded dual-drug eluting biodegradable surgical sutures for prophylaxis against surgical site infections

Key Points

The aim is to develop biodegradable sutures that release antibiotics and anti-inflammatories to prevent infections after surgery.
Engineered sutures using solvent-free hot-melt extrusion.
Sutures deliver immediate and sustained release of levofloxacin and ibuprofen.
Sutures demonstrated effective prevention of surgical site infections.
Showed controlled release of levofloxacin and ibuprofen to manage inflammation.

Abstract

This work engineered biodegradable drug-eluting sutures via solvent-free hot-melt extrusion, enabling immediate and sustained levofloxacin and ibuprofen release to prevent surgical site infections while controlling inflammation.

Engineering matrix-embedded dual-drug eluting biodegradable surgical sutures for prophylaxis against surgical site infections

Key Points

Abstract

Cite This Study